To help BRCA gene mutation induced ovarian cancer patients, the Hong Kong Hereditary Breast Cancer Family Registry launched the Free BRCA Ovarian Cancer Drugs Programme to help disadvantaged families receive the most suitable medication.
All applicants should fulfill the below conditions:
Medical status:
Doctor prescription of programme drug as maintenance therapy
Sensitive to Platinum-based Chemotherapy
BRCA 1 or 2 positive
Relapsed High grade serous epithelial ovarian/fallopian tube/primary peritoneal cancer
Targeted service users:
Hong Kong Identity Card holder
Patients under Hong Kong Hospital Authority
With prescription issued by the Hong Kong Hospital Authority
Financial conditions: Applicants should have a monthly household income of less than HK$ 20,000
*Quotas of the programme will be filled on a first-come-first-served basis
For more information, please consult your doctor.
Please refer to the programme information leaflet for application procedure and documents required
Download Leaflet / Referral Form / Application Form
Click to watch the video.